Publicaciones en las que colabora con Vicente Bertomeu González (33)

2024

  1. β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction

    JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396

2021

  1. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  2. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

2020

  1. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

    Open Heart, Vol. 7, Núm. 2

  2. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

    American Journal of Medicine, Vol. 133, Núm. 3, pp. 370-380.e4

  3. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 463-470

  4. Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

    ESC Heart Failure, Vol. 7, Núm. 6, pp. 3320-3328

  5. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects

    Journal of the American Medical Directors Association, Vol. 21, Núm. 7, pp. 915-918

2019

  1. Hemorrhage in patients under oral anticoagulation for atrial fibrillation. The other side of the coin

    REC: CardioClinics, Vol. 54, Núm. 2, pp. 99-105

  2. Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Trial

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 288-297

  3. International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 616-624

2017

  1. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design

    Revista Espanola de Cardiologia, Vol. 70, Núm. 12, pp. 1067-1073

  2. Prognostic Value of Geriatric Conditions Beyond Age After Acute Coronary Syndrome

    Mayo Clinic Proceedings, Vol. 92, Núm. 6, pp. 934-939

2016

  1. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 21, Núm. 2, pp. 150-156

  2. Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain

    European heart journal. Acute cardiovascular care, Vol. 5, Núm. 5, pp. 399-406

2015

  1. Efecto pronóstico de una estrategia terapéutica guiada por los valores del antígeno carbohidrato 125 (CHANCE-HF). Diseño del estudio

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 121-128

  2. Quality of Anticoagulation with Vitamin K Antagonists

    Clinical Cardiology, Vol. 38, Núm. 6, pp. 357-364

2014

  1. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome

    American Heart Journal, Vol. 168, Núm. 5, pp. 784-791.e2

2012

  1. Antigen carbohydrate 125 and brain natriuretic peptide serial measurements for risk stratification following an episode of acute heart failure

    International Journal of Cardiology, Vol. 159, Núm. 1, pp. 21-28

  2. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure

    European Journal of Heart Failure, Vol. 14, Núm. 9, pp. 974-984